Incyte Corp

Common Name
Incyte
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
2,617
Ticker
INCY
Exchange
NASDAQ/NGS
Description
Incyte Corporation is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics. With a focus on oncology and inflammation, Incyte aims to a...

Financial Statements of Incyte

Below are the financial statements of Incyte, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of USD202420232022
Revenues
Product revenues, net
3,618.89a
3,165.17a
2,746.9a
Product royalty revenues
579.33a
523.48a
482.74a
Milestone and contract revenues
43a
7a
165a
Total revenues
4,241.22a
3,695.65a
3,394.64a
Costs, expenses and other
Cost of product revenues (including definite-lived intangible amortization)
-312.07a
-254.99a
-207a
Research and development
-2,606.85a
-1,627.59a
-1,585.94a
Selling, general and administrative
-1,242.16a
-1,161.29a
-1,002.14a
Loss on change in fair value of acquisition-related contingent consideration
-19.8a
-29.2a
-12.15a
(Profit) and loss sharing under collaboration agreements
-1.03a
2.05a
7.97a
Total costs, expenses and other
-4,179.85a
-3,075.12a
-2,815.2a
Income from operations
61.37a
620.53a
579.44a
Interest income
128.71a
158.41a
40.45a
Interest expense
-2.28a
-2.55a
-2.67a
Realized and unrealized gain (loss) on equity investments
116.03a
43.89a
-87.59a
Other, net
12.81a
13.93a
-0.52a
Income before provision for income taxes
316.63a
834.22a
529.12a
Provision for income taxes
-284.02a
-236.62a
-188.46a
Net income
32.62a
597.6a
340.66a

Verified Sources Behind Incyte’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Incyte’s data sources below and access millions more through our Disclosure Search.

a. Incyte's 10-K 2024
Trace every data point back to Incyte’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?